Stratasys Partners with Siemens Healthineers in Landmark Research Project to Advance Medical Imaging
27 November 2023 - 2:15PM
Business Wire
Stratasys Ltd. (NASDAQ: SSYS), a leader in polymer 3D printing
and additive manufacturing solutions, today announced it has
partnered with Siemens Healthineers to carry out a landmark
research project designed to develop new state-of-the-art solutions
for the advancement of medical imaging phantoms for computed
tomography (CT) imaging.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231127909976/en/
Use of 3D printing may improve outcomes
by providing 3D modeling to provider doctors with real scenarios to
practice and consult with. (Photo: Business Wire)
A critical tool in medical imaging and an almost universal
resource in hospitals worldwide, CT phantoms are specialized
devices used to evaluate and ensure the performance of CT scanners.
Designed to simulate certain characteristics of the human body,
phantoms enable the assessment of various core metrics, including
radiation dose and image quality, aiding calibration and
safeguarding consistent scanner performance. The joint development
leverages Stratasys’ PolyJet™ technology in combination with its
unique RadioMatrix™ technology, and Siemens Healthineers’ advanced
algorithm aimed at translating scanned patient images into specific
material characteristics with radiopacity of human anatomy. The
solution will allow for tailored phantom manufacturing and the
creation of ultra-realistic human anatomy characteristics with
complete radiographic accuracy of patient-specific pathology not
previously possible.
This joint project will transform how phantoms can be utilized
in the medical field, and in certain cases even enable device
manufacturers and academic facilities to replace human cadavers
with 3D printed structures. Having this capability enables critical
efficiencies and minimizes inevitable human variability. This work
will also produce a critical body of research data, providing key
insights for advancing CT system algorithms, driving materials
development, and unlocking potential new application areas – as
well as identifying future research opportunities.
“The current limitations of imaging phantoms have been a
longstanding challenge for the radiology community,” said Erez Ben
Zvi, Vice President Medical at Stratasys. “This partnership with
Siemens Healthineers will enable us to jointly explore the vast
possibilities of our radiopaque materials and 3D printing
technologies to overcome these barriers.”
Beginning with the manufacturing of 3D printed phantoms for
smaller-scale anatomies of the head and neck region, the research
will involve the production of progressively larger and complex
anatomies – leading up to the Phase One endpoint of 3D printing a
heart model and of an entire human torso with complete radiographic
accuracy.
“Knowledge gained from this project provides a breakthrough in
medical imaging that will open up new avenues for uses when it
comes to 3D printing and imaging,” said Lampros Theodorakis, Head
of Computed Tomography Product & Clinical Marketing at Siemens
Healthineers. “We are excited about the opportunities ahead of us
as a result of this partnership and believe it will have long-term
impacts for medical and academic applications.”
About Stratasys
Stratasys is leading the global shift to additive manufacturing
with innovative 3D printing solutions for industries such as
aerospace, automotive, consumer products, healthcare, fashion and
education. Through smart and connected 3D printers, polymer
materials, a software ecosystem, and parts on demand, Stratasys
solutions deliver competitive advantages at every stage in the
product value chain. The world’s leading organizations turn to
Stratasys to transform product design, bring agility to
manufacturing and supply chains, and improve patient care.
To learn more about Stratasys visit www.stratasys.com, the
Stratasys blog, X/Twitter, LinkedIn, or Facebook. Stratasys
reserves the right to utilize any of the foregoing social media
platforms, including the company’s websites, to share material,
non-public information pursuant to the SEC’s Regulation FD. To the
extent necessary and mandated by applicable law, Stratasys will
also include such information in its public disclosure filings.
Note to Editors: High-resolution images and additional
information are available upon request from appropriately listed
media contacts.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231127909976/en/
Investor and Media Contacts
Stratasys Corporate & North America
Chris Reese chris.reese@stratasys.com +1 6651 357 0877
Investor Relations Yonah Lloyd Yonah.Lloyd@stratasys.com
+972 74 745 4919
Europe, Middle East, & Africa Jonathan Wake /
Samantha White, Incus Media stratasys@incus-media.com +44 1737
215200
Brazil, Central America and South America Erica Massini
Erica.Massini@stratasys.com +55 (11) 2626-9229
Stratasys Corporate & Israel Erik Snider
Erik.Snider@stratasys.com +972 74 745 6053
Asia Kalyani Dwivedi Kalyani.Dwivedi@stratasys.com +91 80
6746 2606
Stratasys (NASDAQ:SSYS)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Stratasys (NASDAQ:SSYS)
Historical Stock Chart
Von Mai 2023 bis Mai 2024